FDA Approved: REXULTI — Original Application (Otsuka America Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved Rexulti (brexpiprazole) from Otsuka America Pharmaceutical as the original approval for the treatment of schizophrenia in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• REXULTI (brexpiprazole)

Snippet

ORIG AP for REXULTI (BREXPIPRAZOLE)